SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001511164-14-000518
Filing Date
2014-09-15
Accepted
2014-09-15 16:48:22
Documents
11
Period of Report
2014-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q neurokineform10qq2july312014.htm 10-Q 266563
8 EXHIBIT 31.1 neurokinesection302certceoq2.htm EX-31.1 7903
9 EXHIBIT 31.2 neurokinesection302certcfoq2.htm EX-31.2 8005
10 EXHIBIT 32.1 neurokinesection906certceoq2.htm EX-32.1 5911
11 EXHIBIT 32.2 neurokinesection906certcfoq2.htm EX-32.2 5782
  Complete submission text file 0001511164-14-000518.txt   2734254

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT neukf-20140731.xml EX-101.INS 382792
3 XBRL TACONOMY EXTENSION SCHEMA neukf-20140731.xsd EX-101.SCH 40986
4 XBRL TACONOMY EXTENSION CALCULATION LINKBASE neukf-20140731_cal.xml EX-101.CAL 2941
5 XBRL TACONOMY EXTENSION DEFINITION LINKBASE neukf-20140731_def.xml EX-101.DEF 57693
6 XBRL TACONOMY EXTENSION LABEL LINKBASE neukf-20140731_lab.xml EX-101.LAB 149945
7 XBRL TACONOMY EXTENSION PRESENTATION LINKBASE neukf-20140731_pre.xml EX-101.PRE 139408
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-161157 | Film No.: 141103655
SIC: 2834 Pharmaceutical Preparations